Fibrinolytic system, metalloproteinases and vascular diseases;Système fibrinolytique, métalloprotéases et pathologie vasculaire

Medecine/Sciences

Volumn 17, Issue 2, 2001, Pages 170-176

  Nalbone, G ^a   Alessi, M C ^a   Juhan Vague, I ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ELASTIN; FIBRONECTIN; GELATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMININ; METALLOPROTEINASE;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOT LYSIS; BLOOD VESSEL GRAFT; BLOOD VESSEL INJURY; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; ELECTRIC INJURY; FIBRINOLYSIS; HUMAN; PATHOGENESIS; RESTENOSIS; REVIEW; VASCULAR DISEASE;

EID: 0035101488     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1889     Document Type: Review

References (26)

1. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
2. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice
3. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance
4. PAI-1, obesity, insulin resistance and risk of cardiovascular events
5. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls
6. Impaired arterial neointima formation in mice with disruption of the plasminogen gene
7. Urokinase-type but not tissue type plasminogen activator mediates arterial neointima formation in mice
8. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: A gene targeting and gene transfer study in mice
9. Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries
10. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis
11. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency
12. Urokinase-generated plasmin is a candidate activator of matrix metalloproteinases during atherosclerotic aneurysm formation
13. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1
14. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery
15. Enhanced atherosclerosis in the absence of macrophage plasminogen activator inhibitor-1
16. Reduced transplant arteriosclerosis in plasminogen-deficient mice
17. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1
18. Murine model of accelerated transplant arteriosclerosis
19. Increased expression of matrix metalloproteinases ann matrix degrading activity in vulnerable regions of human atherosclerotic plaques
20. Temporal and topographic matrix metalloproteinase expression after vascular injury in mice
21. The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration
22. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells
23. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice
24. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein
25. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury
26. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells